Pharmaceuticals in Brazil

Summary

Datamonitor's Pharmaceuticals in Mexico industry profile is an essential resource for top-level data and analysis covering the Mexico industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

• Contains an executive summary and data on value, volume and/or segmentation
• Provides textual analysis of the industry's recent performance and future prospects
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Includes a five-year forecast of the industry
• The leading companies are profiled with supporting key financial metrics
• Supported by the key macroeconomic and demographic data affecting the market

Highlights

• Detailed information is included on market size, measured by value and/or volume
• Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
• Market shares are covered by manufacturer or brand

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2007 annual average exchange rates.

The global figure comprises the Americas, Asia-Pacific and Europe.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico, and the US.

Contents

• TABLE OF CONTENTS
• EXECUTIVE SUMMARY
• Chapter 1 Market Overview
  • 1.1 Market Definition
  • 1.2 Research Highlights
  • 1.3 Market Analysis
• Chapter 2 Market Value
• CHAPTER 3 Market Segmentation I
• CHAPTER 4 Market Segmentation II
• Chapter 5 Market Share
• Chapter 6 Five Forces analysis
  • 6.1 Summary
  • 6.2 Buyer Power
  • 6.3 Supplier Power
  • 6.4 New Entrants
  • 6.5 Substitutes
  • 6.6 Rivalry
• Chapter 7 Leading Companies
  • 7.1 Pfizer Inc
  • 7.2 GlaxoSmithKline Plc
  • 7.3 Eli Lilly and Company
  • 7.4 Sanofi-Aventis SA
• Chapter 8 Market Forecasts
  • 8.1 Market Value Forecast
• Chapter 9 Macroeconomic Indicators
• Chapter 1 Appendix
  • 1.1 Methodology
  • 1.2 Industry Associations
  • 1.3 Related Datamonitor Research
• LIST OF TABLES
  • Table 1: Mexico Pharmaceuticals Market Value: $ billion, 2004-2008
  • Table 2: Mexico Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
  • Table 3: Mexico Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
  • Table 4: Mexico Pharmaceuticals Market Share: % Share, by Value, 2008(e)
  • Table 5: Key Facts: Pfizer Inc
  • Table 6: Key Financials: Pfizer Inc
  • Table 7: Key Facts: GlaxoSmithKline Plc
  • Table 8: Key Financials: GlaxoSmithKline Plc
  • Table 9: Key Facts: Eli Lilly and Company
  • Table 10: Key Financials: Eli Lilly and Company
  • Table 11: Key Facts: Sanofi-Aventis SA
  • Table 12: Key Financials: Sanofi-Aventis SA
  • Table 13: Mexico Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
  • Table 14: Mexico Size of Population (million) , 2004-2008
  • Table 15: Mexico GDP (Constant 2000 Prices, $ billion), 2004-2008
  • Table 16: Mexico Inflation, 2004-2008
  • Table 17: Mexico Exchange Rate, 2004-2008